Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

375 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Diagnosis and therapy of nonalcoholic steatohepatitis.
Torres DM, Harrison SA. Torres DM, et al. Among authors: harrison sa. Gastroenterology. 2008 May;134(6):1682-98. doi: 10.1053/j.gastro.2008.02.077. Gastroenterology. 2008. PMID: 18471547 Review.
Nonalcoholic fatty liver disease.
Paredes AH, Torres DM, Harrison SA. Paredes AH, et al. Among authors: harrison sa. Clin Liver Dis. 2012 May;16(2):397-419. doi: 10.1016/j.cld.2012.03.005. Clin Liver Dis. 2012. PMID: 22541706 Review.
Controversies in the Diagnosis and Management of NAFLD and NASH.
Rinella ME, Loomba R, Caldwell SH, Kowdley K, Charlton M, Tetri B, Harrison SA. Rinella ME, et al. Among authors: harrison sa. Gastroenterol Hepatol (N Y). 2014 Apr;10(4):219-27. Gastroenterol Hepatol (N Y). 2014. PMID: 24976805 Free PMC article.
Practice patterns in NAFLD and NASH: real life differs from published guidelines.
Rinella ME, Lominadze Z, Loomba R, Charlton M, Neuschwander-Tetri BA, Caldwell SH, Kowdley K, Harrison SA. Rinella ME, et al. Among authors: harrison sa. Therap Adv Gastroenterol. 2016 Jan;9(1):4-12. doi: 10.1177/1756283X15611581. Therap Adv Gastroenterol. 2016. PMID: 26770262 Free PMC article.
Elafibranor, an Agonist of the Peroxisome Proliferator-Activated Receptor-α and -δ, Induces Resolution of Nonalcoholic Steatohepatitis Without Fibrosis Worsening.
Ratziu V, Harrison SA, Francque S, Bedossa P, Lehert P, Serfaty L, Romero-Gomez M, Boursier J, Abdelmalek M, Caldwell S, Drenth J, Anstee QM, Hum D, Hanf R, Roudot A, Megnien S, Staels B, Sanyal A; GOLDEN-505 Investigator Study Group. Ratziu V, et al. Among authors: harrison sa. Gastroenterology. 2016 May;150(5):1147-1159.e5. doi: 10.1053/j.gastro.2016.01.038. Epub 2016 Feb 11. Gastroenterology. 2016. PMID: 26874076 Free article. Clinical Trial.
A randomized, placebo-controlled trial of cenicriviroc for treatment of nonalcoholic steatohepatitis with fibrosis.
Friedman SL, Ratziu V, Harrison SA, Abdelmalek MF, Aithal GP, Caballeria J, Francque S, Farrell G, Kowdley KV, Craxi A, Simon K, Fischer L, Melchor-Khan L, Vest J, Wiens BL, Vig P, Seyedkazemi S, Goodman Z, Wong VW, Loomba R, Tacke F, Sanyal A, Lefebvre E. Friedman SL, et al. Among authors: harrison sa. Hepatology. 2018 May;67(5):1754-1767. doi: 10.1002/hep.29477. Epub 2018 Jan 29. Hepatology. 2018. PMID: 28833331 Free PMC article. Clinical Trial.
375 results